Genetic Alliance UK

What Genetic Alliance UK does

Genetic Alliance UK is a UK-registered charity, founded in 1989 and headquartered in London, that operates as an alliance of over 220 charities and support groups serving the 3.5 million people in the UK affected by genetic, rare, and undiagnosed conditions. The organization runs two flagship programs: Rare Disease UK, a national advocacy campaign focused on the UK Rare Diseases Framework, and SWAN UK (Syndromes Without A Name), the only dedicated support network in the UK for families of children with undiagnosed genetic conditions. Its core offerings include downloadable Rare Resources guides for England, Scotland, and Wales, an A-Z directory of member organizations, policy reports such as the Good Diagnosis Report and Coordinating Care Report, parliamentary group secretariats (Westminster APPG plus Welsh and Scottish Cross-Party Groups), and annual awareness campaigns including Rare Disease Day and Undiagnosed Children's Day.

The organization has no proprietary technology product. It has no public API, mobile app, or software platform; its 'technology' consists of a content website, email newsletters, social media channels, and Google Forms-based community registration for SWAN UK. Its underlying knowledge assets are policy expertise, lived-experience networks, and clinical and academic relationships rather than software or data infrastructure.

Genetic Alliance UK is funded through a diversified charity revenue model: grants from foundations and government bodies (including a $500,000 grant from the Helmsley Charitable Trust in July 2025 to expand the iHope Genetic Health program), individual and corporate donations, tiered organizational membership fees (free for organizations under £10,000 annual income), and corporate partnerships with life-sciences companies governed by a Working With Life-sciences Industries Policy. It serves four primary customer segments: patient advocacy organizations (members), affected individuals and families, healthcare professionals and researchers, and government bodies and parliamentarians. The organization is governed by a Board of Trustees with nine member-elected and three appointed trustees, and is led by CEO Nick Meade, supported by a senior team spanning research, engagement, public affairs, membership, and corporate partnerships functions.

Name

Genetic Alliance UK

Legal name

Genetic Alliance UK

Website

https://geneticalliance.org.uk

Company type

Private

Founded year

1989

Operating status

Operating

Headcount range

11–50 employees

Short description

Genetic Alliance UK is a London-based charity alliance of over 220 organizations providing advocacy, support, and policy influence for the 3.5 million people in the UK affected by genetic, rare, and undiagnosed conditions.

Ownership category

akta.pro rank

Product category

Patient Advocacy and Rare Disease Support Services

NAICS

Other Individual and Family Services (624190), Child and Youth Services (62411)

SIC

Services-Social Services (8300), Services-Membership Organizations (8600)

akta.pro primary industry

Rare Disease & Special Needs Support Organizations (BPAGACAM)

akta.pro secondary industry

Genetic & Prenatal Testing Laboratories (HLAFAMAH)

Keywords

• Rare disease advocacy
• Patient alliance network
• Genetic condition support
• Policy advocacy services
• Community support network

Headquarters

HQ city

London

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Grant Funding: Primary revenue stream from charitable foundations and government bodies. The Helmsley Charitable Trust awarded $500,000 for the iHope Genetic Health program expansion. Additional funding from The National Lottery Community Fund for SWAN UK, Scottish Government for Rare Resources Scotland, and industry partners for Rare Resources England.
2. Donations: Individual and corporate donations to support the charity's work improving lives of those affected by genetic, rare and undiagnosed conditions. The organization runs fundraising campaigns and accepts one-off, monthly or annual donations.
3. Membership Fees: Membership is free for organizations with annual income under £10,000. Organizations above this threshold pay annual membership fees based on organizational income tiers. This provides a small but consistent revenue stream while keeping the alliance accessible to small patient groups.
4. Corporate/Industry Partnerships: Partnerships with life-sciences industry companies who support Rare Disease UK campaign, Rare Disease Day, and community appeals. The organization has a 'Working With Life-sciences Industries Policy' governing these relationships.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels12 records

Core offering

Genetic Alliance UK is a UK charity alliance of over 220 patient organisations that provides advocacy, support and information services for people affected by genetic, rare and undiagnosed conditions. Its core offerings include the Rare Disease UK campaign, the SWAN UK support network for families of children with undiagnosed conditions, Rare Resources guides across England, Scotland and Wales, a member organisations directory, policy reports, parliamentary group secretariats, and awareness campaigns such as Rare Disease Day and Undiagnosed Children's Day.

Product overview

Genetic Alliance UK is a charity alliance of over 220 member organizations providing advocacy, support, and information services for the 3.5 million people in the UK affected by genetic, rare and undiagnosed conditions. The organization operates two flagship programs: Rare Disease UK (a national advocacy campaign) and SWAN UK (the only dedicated support network for families of children with undiagnosed genetic conditions). Core offerings include Rare Resources guides for families across England, Scotland, and Wales, a member organizations directory, policy reports and research publications, parliamentary group secretariats, and educational resources including the Seeking a Rare Diagnosis guides. The organization also runs Undiagnosed Children's Day awareness campaigns and publishes newsletters to keep the community informed. This is not a technology product company but a charitable advocacy organization.

Differentiator

Problem solved

Functional benefit

Brands

• Rare Disease UK: A long-standing national campaign by Genetic Alliance UK that represents and unites everyone in the rare disease community, providing a united voice and raising awareness through Rare Disease Day.
• SWAN UK

Products and services

• Rare Disease UK A long-standing national campaign by Genetic Alliance UK that represents and unites everyone in the rare disease community, providing a united voice for policy influencing and raising awareness through Rare Disease Day.
• SWAN UK (Syndromes Without A Name) The only dedicated support network in the UK for families affected by a syndrome without a name — a genetic condition so rare it often remains undiagnosed. Provides community, information, events, and educational outreach for families of children with undiagnosed genetic conditions.
• Rare Resources Guides Downloadable toolkit guides of information and sources of support for people living with genetic, rare and undiagnosed conditions in England, Scotland, and Wales, covering topics such as genetic conditions explained, journey to diagnosis, NHS usage, and support for parents and carers.
• Member Organisations Directory An A-Z alphabetical directory of over 220 member organisations representing various genetic and rare conditions, enabling individuals to find appropriate support groups and organisations for their specific conditions.
• Genetic and Rare News Newsletter A regular newsletter providing news, updates, and opportunities from the genetic and rare community, keeping subscribers informed about the organisation's work and developments in the field.
• Policy Reports and Research Publications Published reports including the Good Diagnosis Report and Coordinating Care Report that highlight the crucial role of timely diagnosis and better connected care for people with genetic, rare or undiagnosed conditions.
• Parliamentary Group Secretariats Genetic Alliance UK provides the secretariat for parliamentary groups including Westminster APPG, Welsh CPG, and Scottish CPG on Rare, Genetic and Undiagnosed Conditions, connecting the rare disease community with policymakers.
• Seeking a Rare Diagnosis Guides Guides for adults and children seeking a diagnosis using NHS services in England, providing practical guidance through the diagnostic process.
• Undiagnosed Children's Day An annual awareness day held on the last Friday in April to increase awareness of undiagnosed genetic conditions and raise funds for SWAN UK.

Quantifiable outcome

• Diagnose over 75,000 patients in five years through iHope Genetic Health program expansion
• +2 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered supporting and core.

• Life-sciences Industry PartnerssupportingStrategic or Co-development PartnerCorporate partners supporting the Rare Disease UK campaign, Rare Disease Day, and community appeals. Relationships governed by Working With Life-sciences Industries Policy. Justin Khodaiji leads corporate partnerships as Head of Corporate Partnerships.
• Genomics EnglandcoreStrategic or Co-development PartnerPartnership on guidance development for engaging with small patient advocacy groups. Funded by Genomics England, Genetic Alliance UK developed guidance to help large organizations engage with small patient groups proportionately.
• UniquesupportingStrategic or Co-development PartnerCollaboration with Unique (member organization) and Genomics England to develop 'how to' toolkit for creating accessible condition-specific information that can be used by charities, support groups, patient groups and the NHS.

Scale indicators7 records

Recent moves6 records

Expansion highlights12 records

Direct peers

• Rare Diseases International: Global alliance of rare disease patient organizations providing a unified international voice. Comparable as a higher-level alliance umbrella organization pursuing shared advocacy objectives across geographies.
• Ataxia UK: UK rare disease charity for people with ataxias, led for 15 years by Sue Millman (now Genetic Alliance UK's Vice Chair). Comparable as a condition-specific rare disease patient support and research charity with deep UK policy engagement.
• National Organization for Rare Disorders (NORD): US-based patient advocacy organization for rare diseases with a similar mission of uniting patient organizations, providing resources, and influencing policy. Operates the US rare disease framework analogous to Genetic Alliance UK's role in the UK framework.
• Muscular Dystrophy UK: One of Genetic Alliance UK's 220+ member organizations and a major UK rare disease charity. Comparable as a condition-specific rare disease patient advocacy and support charity operating under the alliance umbrella.
• Cystic Fibrosis Trust: Major UK rare disease charity and Genetic Alliance UK member. Comparable as a well-established, condition-specific rare disease support and research charity operating within the same UK rare disease ecosystem.
• EURORDIS - Rare Diseases Europe: European alliance of over 1,000 rare disease patient organizations operating as a non-profit federation. Directly comparable as a peer charity alliance serving rare disease communities, but at European rather than UK level.

Emerging players

• Medics 4 Rare Diseases: UK charity focused on medical education and awareness for rare diseases. Comparable as a smaller, emerging UK-based rare disease advocacy organization addressing an adjacent mission around clinician education and diagnosis.
• Genomics England: UK government-owned company running the 100,000 Genomes Project and the Generation Study for newborn genomic screening. Directly relevant as a current strategic partner (Genetic Alliance UK developed engagement guidance for them) and as a fellow player in UK genomic medicine policy.

Broad incumbents

• Wellcome Trust: Large UK charitable foundation funding health research including rare disease genomics. Comparable as a UK health-focused philanthropic entity with significantly larger capital base and broader research funding remit.
• Cancer Research UK: Largest UK health research charity by income. Comparable as a UK health charity operating at much greater scale, using parliamentary engagement, public campaigns, and industry partnerships to drive policy and research impact across a broader disease area.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/GeneticAll_UK
• YouTubeyoutube.com/@GeneticAlliance_UK
• Facebookfacebook.com/GeneticAllianceUK
• Instagraminstagram.com/rarediseaseuk

Revenue estimate

Valuation estimate

Number of profiles

Profiles21 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Genetic Alliance UK